This program is studying a compound designed to block the function of the sodium (Na+) channel found in the lungs. These channels move sodium and water awat from the airway surface. Blocking these channels may help maintain fluid within the airways to imprive mucus clearance.
Laboratory studies to develop and test this compound are underway.
This program is sponsored by Ionis Pharmaceuticals and partially funded by the Cystic Fibrosis Foundation's Therapeutics Development Network.
Contact us about Ionis >